In This Section

[Abstract #228] Improving Care for Patients With Stage III/IV NSCLC: Learnings for Multidisciplinary Teams at ASCO QCS

October 9, 2020

Presented at the 2020 ASCO Quality Care Symposium, October 9 to October 10, 2020.


Ravi Salgia1; Leigh M. Boehmer2; Catherine Celestin3; Hong Yu3; David R. Spigel4

1Department of Medical Oncology and Therapeutics Research, City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA, USA; 2Editorial Content & Strategy, Association of Community Cancer Centers, Rockville, MD, USA; 3Oncology Group, AstraZeneca, Gaithersburg, MD, USA; 4Lung Cancer Research Program, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA


The Association of Community Cancer Centers (ACCC) has designed a quality metric for ideal NSCLC care, which has guided the development of a national survey to improve understanding of diagnosis and management of patients with stage III/IV NSCLC across different U.S.-based practice settings and to design and execute process improvement plans to address the identified barriers.
Download Supplement

Video Summary



CCMED_MDT Survey Abstract Infographic_May_29_2020
Download Infographic


ACCC Buzz Blog Post


ASCO Abstract: What Defines Quality Lung Cancer Care?
June 12, 2020

Our Partners



Our Supporter


This project is made possible by support from AstraZeneca.